Glucosamine Sulphate and Increased Level of Blood Cholesterol

This study has been completed.
Sponsor:
Collaborator:
Pharma Nord
Information provided by:
Slidgigtinstituttet
ClinicalTrials.gov Identifier:
NCT00251069
First received: November 7, 2005
Last updated: NA
Last verified: July 2005
History: No changes posted
  Purpose

Glucosamine sulphate causes no changes in blood levels of cholesterol


Condition Intervention Phase
Osteoarthritis
Drug: Glucosamine sulphate
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Glucosamine Sulphate and Hypercholesterolaemia

Resource links provided by NLM:


Further study details as provided by Slidgigtinstituttet:

Primary Outcome Measures:
  • Levels of blood cholesterol

Secondary Outcome Measures:
  • Effect of treatment on pain

Estimated Enrollment: 66
Study Start Date: April 2005
Estimated Study Completion Date: August 2005
Detailed Description:

The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels -

Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00251069

Locations
Denmark
Slidgigtinstituttet
Ishøj, Denmark, DK-2635
Sponsors and Collaborators
Slidgigtinstituttet
Pharma Nord
Investigators
Principal Investigator: Keld Ostergaard, M.D., Ph.D. Slidgigtinstituttet
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00251069     History of Changes
Other Study ID Numbers: EudraCTnr 2005-000541-11
Study First Received: November 7, 2005
Last Updated: November 7, 2005
Health Authority: Denmark: Lægemiddelstyrelsen (Danish Health Authorities)

Keywords provided by Slidgigtinstituttet:
glucosamine sulphate, osteoarthritis, cholesterol,

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on October 20, 2014